LIGAND PHARMACEUTICALS INCORPORATED Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum
LIGAND PHARMACEUTICALS INCORPORATED (LGND) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum of 1.70% for the 12-month period ending 2015-12-31, per its 10-K filed 2016-11-14.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum · last filed 2016-11-14
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for the quarter ending 2015-06-30 was 1.70%, a 10.53% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for the quarter ending 2015-03-31 was 1.80%, a 5.26% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for the quarter ending 2014-09-30 was 1.90%, a 5.56% increase year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for the quarter ending 2014-06-30 was 1.90%, a 35.71% increase year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2015 was 1.70%, a 50.44% increase from fiscal 2014.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2014 was 1.13%, a 0.00% change from fiscal 2013.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2013 was 1.13%, a 36.14% increase from fiscal 2012.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2012 was 0.83%, a 23.85% decline from fiscal 2011.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 12 month as first filed |
|---|---|---|---|---|---|
| 2015-12-31 | 1.70% 10-K · filed 2016-11-14 | ||||
| 2015-09-30 | 1.70% 10-Q · filed 2015-11-09 | ||||
| 2015-06-30 | 1.70% 10-Q · filed 2015-08-05 | 1.80% 10-Q · filed 2015-08-05 | |||
| 2015-03-31 | 1.80% 10-Q · filed 2015-05-11 | ||||
| 2014-12-31 | 1.13% 10-K · filed 2014-12-01 | ||||
| 2014-09-30 | 1.90% 10-Q · filed 2014-10-31 | 1.90% 10-Q · filed 2014-10-31 | |||
| 2014-06-30 | 1.90% 10-Q · filed 2015-08-05 | 1.90% 10-Q · filed 2015-08-05 | |||
| 2014-03-31 | 1.90% 10-Q · filed 2015-05-11 | ||||
| 2013-12-31 | 1.13% 10-K · filed 2016-11-14 | ||||
| 2013-09-30 | 1.80% 10-Q · filed 2014-10-31 | 1.40% 10-Q · filed 2014-10-31 | |||
| 2013-06-30 | 1.40% 10-Q · filed 2014-08-05 | 1.30% 10-Q · filed 2014-08-05 | |||
| 2013-03-31 | 1.10% 10-Q · filed 2014-05-07 | ||||
| 2012-12-31 | 0.83% 10-K · filed 2015-02-23 | 1.10% 10-K · filed 2013-03-14 | |||
| 2012-09-30 | 0.80% 10-Q · filed 2013-11-08 | 1.00% 10-Q · filed 2013-11-08 | |||
| 2012-06-30 | 0.90% 10-Q · filed 2013-08-01 | 1.00% 10-Q · filed 2013-08-01 | |||
| 2012-03-31 | 1.10% 10-Q · filed 2013-05-08 | ||||
| 2011-12-31 | 1.09% 10-K/A · filed 2014-12-12 | 2.50% 10-K · filed 2013-03-14 | |||
| 2011-09-30 | 1.70% 10-Q · filed 2012-11-14 | 2.50% 10-Q · filed 2012-11-14 | |||
| 2011-06-30 | 2.40% 10-Q/A · filed 2012-11-14 | 2.50% 10-Q/A · filed 2012-11-14 | |||
| 2010-12-31 | 2.70% 10-K · filed 2013-03-14 |